Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma

MLA

Wu, Chi-Sheng, et al. “Heterogeneous Ribonucleoprotein K and Thymidine Phosphorylase Are Independent Prognostic and Therapeutic Markers for Oral Squamous Cell Carcinoma.” Oral Oncology, vol. 48, no. 6, June 2012, pp. 516–22. EBSCOhost, https://doi.org/10.1016/j.oraloncology.2012.01.005.

APA

Wu, C.-S., Chang, K.-P., Chen, L.-C., Chen, C.-C., Liang, Y., Hseuh, C., & Chang, Y.-S. (2012). Heterogeneous ribonucleoprotein K and thymidine phosphorylase are independent prognostic and therapeutic markers for oral squamous cell carcinoma. Oral Oncology, 48(6), 516–522. https://doi.org/10.1016/j.oraloncology.2012.01.005

Chicago

Wu, Chi-Sheng, Kai-Ping Chang, Lih-Chyang Chen, Chia-Chun Chen, Ying Liang, Chuen Hseuh, and Yu-Sun Chang. 2012. “Heterogeneous Ribonucleoprotein K and Thymidine Phosphorylase Are Independent Prognostic and Therapeutic Markers for Oral Squamous Cell Carcinoma.” Oral Oncology 48 (6): 516–22. doi:10.1016/j.oraloncology.2012.01.005.